Officials within the Israeli Ministry of Health have determined that the mRNA “vaccine” from Pfizer and BioNTech is “probably” linked to causing deadly heart inflammation, particularly in young men, following the second dose.
After receiving a litany of reports about cases of heart inflammation, including myocarditis, post-injection, a panel of public health experts specializing in epidemiology, along with members of numerous respected universities, decided to take a close look at the jab to see if any correlation between the two exists.
They found that the experimental gene therapy injections inflame the heart muscle, potentially leading to cardiac arrhythmia and death. Researchers from the National Organization for Rare Disorders says that myocarditis can result from infection, but is more commonly “the result of the body’s immune reaction to the initial heart damage.”
Some 275 cases of myocarditis were identified between December 2020 and May 2021, including 148 cases that occurred within one month after vaccination. Of these, 27 occurred after the first dose and 121 occurred after the second dose.
Many of the cases were identified in men between the ages of 16 and 30, and most were in the specific age range between 16 and 19. A majority of the cases were categorized as “mild,” with most leaving the hospital in less than four days, but the phenomenon is still of great concern.
“There is a likelihood of a connection between receiving a second dose of vaccine and the onset of myocarditis in young men aged 16-30,” the panel concluded. “The connection is stronger in young people aged 16-19 compared to other ages and it decreases as age increases.”
Accoring to Dror Mevorach, who heads up the internal medicine department at the Hadassah Medical Center, the findings are “very suggestive of a causal nature” between Pfizer-BioNTech mRNA injections and prolific heart inflammation, especially in younger men.
“I am convinced there is a relationship,” he is quoted as saying.
Peter Liu, a cardiologist and the chief scientific officer at the University of Ottawa Heart Institute, agrees, noting that statistically speaking this is “a real phenomenon.”
Pfizer, of course, denies all links, insisting its experimental gene therapy injections are completely “safe and effective.” Only crazy “conspiracy theorists,” the company suggested, would believe otherwise.
More than 300 million doses of the Pfizer-BioNTech jab have been administered globally thus far, and the “benefit-risk profile” still remains “positive,” the company insists.
Israel and a number of European countries, however, are not convinced. There is now a push to stop all vaccination of young children based on the findings, though an official decision has not been made.
Some of these countries have yet to even include the 12-15 age group that the United States already has, and could avoid doing so indefinitely. Pfizer-BioNTech will almost certainly fight against this, as the companies hope to inject all age groups at “warp speed” in order to keep everyone “safe” against the Chinese Virus.
European Union regulators are calling on both Pfizer and Moderna to procure additional data about their respective mRNA injections showing that they are safe with regards to heart inflammation. The U.S. Centers for Disease Control and Prevention (CDC) also claims to be investigating the matter.
The CDC’s Vaccine Adverse Events Reporting System (VAERS) currently shows 419 cases of pericarditis and myocarditis that were reported during roughly the same period as the aforementioned cases in Israel. More than half of these are attributed to the Pfizer-BioNTech jab.
“I’ve never heard as much hedging as I have in the medical field in the last year,” wrote one LifeSiteNews commenter. “Nobody wants to admit causation or imply it.”
More of the latest news about covid vaccine injuries and deaths can be found at ChemicalViolence.com.
Sources for this article include:
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.